ARE HEALTHY-YEARS EQUIVALENTS AN IMPROVEMENT OVER QUALITY-ADJUSTED LIFE YEARS

被引:49
作者
JOHANNESSON, M
PLISKIN, JS
WEINSTEIN, MC
机构
[1] HARVARD UNIV,SCH PUBL HLTH,DEPT HLTH POLICY & MANAGEMENT,677 HUNTINGTON AVE,BOSTON,MA 02115
[2] STOCKHOLM SCH ECON,CTR HLTH ECON,STOCKHOLM,SWEDEN
[3] BEN GURION UNIV NEGEV,DEPT IND ENGN & MANAGEMENT,IL-84105 BEER SHEVA,ISRAEL
基金
美国医疗保健研究与质量局;
关键词
QUALITY-ADJUSTED LIFE YEARS; HEALTHY-YEARS EQUIVALENTS; ECONOMIC EVALUATION; MEDICAL DECISION MAKING; INDIVIDUAL PREFERENCES; TIME-TRADEOFF; STANDARD GAMBLE; UTILITY THEORY;
D O I
10.1177/0272989X9301300403
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The construct of the healthy-years equivalent (HYE) has been proposed as an alternative to the quality-adjusted life year (QALY) on the grounds that it avoids certain restrictive assumptions about preferences and also incorporates attitudes toward risk. The authors review the construct of the QALY, including both the commonly used risk-neutral formulation and the more general formulation that permits risk aversion (or risk preference) with respect to remaining life years. They show that the HYE adds flexibility to the risk-neutral form of the QALY by permitting the rate of tradeoff between life years and quality of life to depend on the life span, albeit at the cost of eliciting numerous additional time-tradeoff assessments. However, the claim that the HYE incorporates attitudes toward risk is incorrect, and the proposed two-stage procedure to measure HYEs is neither necessary nor sufficient to incorporate attitudes toward risk. In fact, the HYE assumes risk neutrality with respect to healthy years of life and, therefore, is less suitable for decisions under uncertainty than is the general (risk-averse) form of the QALY.
引用
收藏
页码:281 / 286
页数:6
相关论文
共 24 条
[1]  
ACTON JP, 1973, RAND R950RC REP
[2]   ECONOMIC-EVALUATION OF NEONATAL INTENSIVE-CARE OF VERY-LOW-BIRTH-WEIGHT INFANTS [J].
BOYLE, MH ;
TORRANCE, GW ;
SINCLAIR, JC ;
HORWOOD, SP .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (22) :1330-1337
[3]  
Bush J.W., 1973, HLTH STATUS INDEXES
[4]   WILLINGNESS TO PAY FOR ANTIHYPERTENSIVE THERAPY - RESULTS OF A SWEDISH PILOT-STUDY [J].
JOHANNESSON, M ;
JONSSON, B ;
BORGQUIST, L .
JOURNAL OF HEALTH ECONOMICS, 1991, 10 (04) :461-474
[5]  
JONSSON B, 1976, COST BENEFIT ANAL PU
[6]   COST EFFECTIVENESS ANALYSIS APPLIED TO TREATMENT OF CHRONIC RENAL DISEASE [J].
KLARMAN, HE ;
FRANCIS, JO ;
ROSENTHAL, GD .
MEDICAL CARE, 1968, 6 (01) :48-54
[7]   THE USE OF QALYS IN HEALTH-CARE DECISION-MAKING [J].
LOOMES, G ;
MCKENZIE, L .
SOCIAL SCIENCE & MEDICINE, 1989, 28 (04) :299-308
[8]   SPEECH AND SURVIVAL - TRADEOFFS BETWEEN QUALITY AND QUANTITY OF LIFE IN LARYNGEAL-CANCER [J].
MCNEIL, BJ ;
WEICHSELBAUM, R ;
PAUKER, SG .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 305 (17) :982-987
[9]   THE HEALTHY-YEARS EQUIVALENTS - HOW TO MEASURE THEM USING THE STANDARD GAMBLE APPROACH [J].
MEHREZ, A ;
GAFNI, A .
MEDICAL DECISION MAKING, 1991, 11 (02) :140-146
[10]   QUALITY-ADJUSTED LIFE YEARS, UTILITY-THEORY, AND HEALTHY-YEARS EQUIVALENTS [J].
MEHREZ, A ;
GAFNI, A .
MEDICAL DECISION MAKING, 1989, 9 (02) :142-149